Matrix reloaded to circulation hits the tumor target

Cancer Cell

Volumn 3, Issue 6, 2003, Pages 513-514

  Wickström, Sara A ^a   Keski Oja, Jorma ^a   Alitalo, Kari ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA5 INTEGRIN; ANGIOGENESIS INHIBITOR; ANGIOGENIC FACTOR; ANTIBODY; BETA1 INTEGRIN; BETA3 INTEGRIN; COLLAGEN TYPE 4; ENDOSTATIN; FOCAL ADHESION KINASE; GELATINASE B; INTEGRIN; MATRIX METALLOPROTEINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN SUBUNIT; PROTEIN TYROSINE KINASE; RAS PROTEIN; RHO KINASE; TUMSTATIN; UNCLASSIFIED DRUG; VASCULOTROPIN; VIRUS VECTOR;

ALPHA CHAIN; ANGIOGENESIS; ANTIGEN BINDING; BIOAVAILABILITY; CANCER CELL; CANCER INHIBITION; CANCER STAGING; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CELL ACTIVATION; CELL ADHESION; CELL FUNCTION; CELL MIGRATION; CELL SURFACE; CORRELATION ANALYSIS; DISEASE SEVERITY; DOWN REGULATION; DRUG POTENTIATION; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME ASSAY; EXTRACELLULAR MATRIX; GENE TARGETING; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN SYNTHESIS; PROTEIN TARGETING; REGULATORY MECHANISM; SHORT SURVEY; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; TUMOR GROWTH; TUMOR VASCULARIZATION; TUMOR VOLUME; UPREGULATION;

MUS MUSCULUS;

EID: 0037710319     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1535-6108(03)00143-0     Document Type: Review

References (14)

1. Bergers G., Benjamin L.E. Nat. Rev. Cancer. 3:2003;401-410.
2. Dixelius J., Cross M., Matsumoto T., Sasaki T., Timpl R., Claesson-Welsh L. Cancer Res. 62:2002;1944-1947.
3. Egeblad M., Werb Z. Nat. Rev. Cancer. 2:2002;161-174.
4. Ferrara N. Nat. Rev. Cancer. 2:2002;795-803.
5. Hamano Y., Zeisberg M., Sugimoto H., Lively J.C., Maeshima Y., Yang C., Hynes R.O., Werb Z., Sudhakar A., Kalluri R. Cancer Cell. 3:2003;589-601. this issue,
6. Hynes R. Cell. 110:2002;673-687.
7. Kerbel R., Folkman J. Nat. Rev. Cancer. 2:2002;727-739.
8. Kim S., Bell K., Mousa S.A., Varner J.A. Am. J. Pathol. 156:2000;1345-1362.
9. Maeshima Y., Sudhakar A., Lively J.C., Ueki K., Kharbanda S., Kahn C.R., Sonenberg N., Hynes R.O., Kalluri R. Science. 295:2002;140-143.
10. Rehn M., Veikkola T., Kukk-Valdre E., Nakamura H., Ilmonen M., Lombardo C., Pihlajaniemi T., Alitalo K., Vuori K. Proc. Natl. Acad. Sci. USA. 98:2001;1024-1029.
11. Reynolds L.E., Wyder L., Lively J.C., Taverna D., Robinson S.D., Huang X., Sheppard D., Hynes R.O., Hodivala-Dilke K.M. Nat. Med. 8:2002;27-34.
12. Sudhakar A., Sugimoto H., Yang C., Lively J., Zeisberg M., Kalluri R. Proc. Natl. Acad. Sci. USA. 100:2003;4766-4771.
13. Stupack D.G., Cheresh D.A. Sci. STKE. 119:2002;E7.
14. Wickström S.A., Alitalo K., Keski-Oja J. Cancer Res. 62:2002;5580-5589.